Clinical Trial Update: Safety and Tolerability Study of Ragweed SLIT Tablets [Phase 1]

View source ↗

Summary

A Phase 1 safety and tolerability study of ragweed pollen SLIT tablets completed, evaluating tolerability in individuals with ragweed-related allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis Due to Ragweed Pollen
• Seasonal Allergic Rhinitis

Drugs mentioned

• Ragweed SLIT tablets (ragweed pollen extract sublingual immunotherapy tablet)

Snippet

Sponsor: Stallergenes Greer | Conditions: Rhinitis, Allergic, Seasonal, Ragweed Pollen Allergy | Phase 1 | Status: COMPLETED